Singapore Equity Picks
We continue to expect the Singapore market to trade sideways, with tariff-related newsflow likely to remain fluid in the weeks ahead. STI’s support levels are at 3500 and 3430, and resistance at 3635, 3727. Earlier this month, we took the opportunity to deploy idle cash, adding STI ETF, SATS and raised our exposure to UMS when the STI fell to 3400. With the market rebounding over the past week, we are now paring back exposure and raising our cash levels to be better positioned to capitalise on new opportunities ahead. The reduction in these 3 stocks we added recently is not due to any change in view, but to maintain a more balanced portfolio weight across our picks.
STI ETF: Reduce by 3,000 shares @ SGD3.63
There remains 7,000 shares in equity picks post reduction.
SATS: Reduce by 5,000 shares @ SGD2.67
There remains 10,000 shares in equity picks post reduction.
UMS: Reduce by 10,000 shares @ SGD1
There remains 20,000 shares in equity picks post reduction.
Monthly Review: Staying agile amid volatility
Trending Sector
Singapore REITs
Stocks to Watch
Riding on India’s resilience
Aztech Global
Steep plunge in 1Q25 results on demand weakness, below expectations
Maintain FULLY VALUED rating and SGD0.52TP. We believe current share price is likely supported by SGD10cts DPS, going ex-dividend on 17th April 2025, but is unlikely to be sustained thereafter
Log in or view as guest for stock ideas and more at
GENERAL DISCLOSURE/DISCLAIMER
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). This report is intended for “Accredited Investors” and “Institutional Investors” (defined under the Financial Advisers Act and Securities and Futures Act of Singapore, and their subsidiary legislation), as well as “Professional Investors” (defined under the Securities and Futures Ordinance of Hong Kong) only. It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 13th Floor One Island East, 18 Westlands Road, Quarry Bay, Hong Kong SAR.